Convalescent plasma therapy in COVID-19

dc.contributor.authorUysal, Ayse
dc.contributor.authorErkurt, Mehmet Alı
dc.contributor.authorKuku, Irfan
dc.contributor.authorSarıcı, Ahmet
dc.contributor.authorBiçim, Soykan
dc.contributor.authorKaya, Emin
dc.contributor.authorBerber, Ilhami
dc.date.accessioned2026-08-12T15:37:05Z
dc.date.issued2022
dc.departmentFırat Üniversitesi
dc.description.abstractThe coronavirus disease 2019 (COVID?19) affected many people in a short time and 5-10% of them were severely affected by the disease. A variety of treatment methods\rhave been developed for this rapidly spreading disease and vaccine studies have been initiated. One of these treatment methods is convalescent plasma (CP) therapy which\ris a passive immunization therapy. CP method is based on the principle of giving the plasma containing the antibodies formed against the pathogen to people who have\ractive disease after they have recovered from the disease which is a very effective but short-term solution until a definitive and permanent treatment (vaccine, drug, etc.)\ris found in pandemic conditions. Here, we presented the use of CP in the COVID-19 pandemic.
dc.identifier.doi10.5455/medscience.2021.09.292
dc.identifier.endpage923
dc.identifier.issn2147-0634
dc.identifier.issue2
dc.identifier.startpage920
dc.identifier.trdizinid529901
dc.identifier.urihttps://doi.org/10.5455/medscience.2021.09.292
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/529901
dc.identifier.urihttps://hdl.handle.net/11508/35301
dc.identifier.volume11
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofMedicine Science
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.relation.tubitakinfo:eu-repo/grantAgreement/TUBITAK//
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_TR-Dizin_20260511
dc.subjectGenel ve Dahili Tıp
dc.subjectMikrobiyoloji
dc.titleConvalescent plasma therapy in COVID-19
dc.typeReview Article

Dosyalar